Cue Health to develop omicron-specific test through HHS partnership

HHS' Biomedical Advanced Research and Development Authority will provide additional funds to its ongoing partnership with San Diego-based Cue Health, a healthcare technology company, to develop an omicron-genotyping COVID-19 test.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive